Private Equity International | Lincoln International Aims for New Segment in Private Fund Advisory

Feb 2022

Originally published by Private Equity International on February 9, 2022.

A recent feature in Private Equity International highlights Lincoln’s newest service, Private Funds Advisory.

Click here to view the full article.

Summary

Related Perspectives

Cybersecurity Report: Q3 2022

Q3 2022 cyber mergers and acquisitions (M&A) continue to demonstrate relative buoyancy. Year-to-date (YTD) Q3 2022 cybersecurity M&A volume of $25 billion, while a decline compared to 2021’s record of $49… Read More

Q3 2022 Lincoln Senior Debt Index

The LSDI returned 0.7% for Q3; essentially unchanged from Q2. This represented the fourth lowest return since the inception of the LSDI in Q4 2014.

An Overview of the Lincoln Senior Debt Index

The Lincoln Senior Debt Index is a quarterly index that tracks the fair market value of 500+ middle market, direct lending credit investments every quarter across approximately 100 fund clients.… Read More

In Vivo Pharma Intelligence | The Growth Path for Drug Discovery Partners

Originally published by In Vivo Pharma Intelligence on November 15, 2022 James West, Director in Lincoln’s Healthcare Group, explains the key trends and mergers and acquisitions (M&A) dynamics in the… Read More